April 19, 2024
The US Food and Drug Administration (FDA) has approved the subcutaneous administration of vedolizumab (Entyvio) for maintenance therapy in adults with moderately to severely active Crohn’s […]
April 17, 2024
The US Food and Drug Administration (FDA) has approved the biosimilar ustekinumab-aekn (Selarsdi) for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis in […]
April 16, 2024
At least 19 people from nine states have reported serious reactions after receiving botulinum toxin injections from unlicensed or untrained individuals or in non-healthcare settings, such […]
April 15, 2024
The U.S. Food and Drug Administration (FDA) has approved a medical device named the Sepsis ImmunoScore, which is an artificial intelligence/machine learning software, to guide rapid […]
April 11, 2024
Benralizumab is now approved by the US Food and Drug Administration for the treatment of asthma in children older than 6 years. Marketed as Fasenra, the […]